Company page

Relmada Therapeutics, Inc.

Relmada Therapeutics, Inc. is a public company traded under the ticker RLMD in the American market. With a market capitalization of approximately $705.9 million, Relmada focuses on developing innovative therapies for chronic pain and other conditions. The company is dedicated to advancing its pipeline of drug candidates to address unmet medical needs.